Cargando…

Anti-CGRP in cluster headache therapy: a response

Detalles Bibliográficos
Autores principales:	Wenzel, Richard, Bardos, Jennifer, Aurora, Sheena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419360/ https://www.ncbi.nlm.nih.gov/pubmed/32266593 http://dx.doi.org/10.1007/s10072-020-04335-3

Ejemplares similares

Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
por: Haanes, Kristian Agmund, et al.
Publicado: (2020)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

Calcitonin Gene-Related Peptide (CGRP) and Cluster Headache
por: Carmine Belin, Andrea, et al.
Publicado: (2020)

CGRP in Primary Headaches
por: Edvinsson, Lars
Publicado: (2001)

Methyprednisolone i.v. alters levels of CGRP and melatonin in cluster headache patients
por: Neeb, L, et al.
Publicado: (2013)

CGRP and the Trigeminal System in Migraine
por: Iyengar, Smriti, et al.
Publicado: (2019)

Botulinum toxin type-A therapy in cluster headache: a novel molecular mechanism
por: Namazi, Hamid
Publicado: (2008)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Temporary pacemaker in refractory cluster headache treated with verapamil
por: Perciaccante, A., et al.
Publicado: (2007)

Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Nichols, Russell, et al.
Publicado: (2019)

Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review
por: Dodick, David W., et al.
Publicado: (2022)

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment
por: Láinez, Miguel J. A., et al.
Publicado: (2021)

The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats
por: Vogler, Birgit, et al.
Publicado: (2023)

Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database()
por: Rochoy, Michaël, et al.
Publicado: (2022)

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment
por: Dodick, David W, et al.
Publicado: (2020)

Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache
por: Kudrow, David, et al.
Publicado: (2020)

Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache
por: Pensato, Umberto, et al.
Publicado: (2022)

Benign Headache in the Elderly – A Case Report of Hypnic Headache
por: Kerr, E, et al.
Publicado: (2006)

A patient with primary sexual headache associated with hypnic headaches
por: Porta-Etessam, Jesús, et al.
Publicado: (2009)

Anti-neuronal antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis
por: Kürtüncü, Murat, et al.
Publicado: (2008)

Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache
por: Andrews, J Scott, et al.
Publicado: (2021)

Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
por: Tso, Amy R., et al.
Publicado: (2017)

CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury
por: Ashina, Håkan, et al.
Publicado: (2022)

Nummular Headache: A Rare Headache Type in a Child Responding to Carbamazepine and Gabapentin
por: Panda, Prateek Kumar, et al.
Publicado: (2021)

Post-spinal headache in a parturient - look beyond post-dural puncture headache
por: Prashanth, Anitha, et al.
Publicado: (2016)

Thyroid dysfunction and headache
por: Larner, A. J.
Publicado: (2006)

A neglected case of headache
por: Karoli, Ritu, et al.
Publicado: (2013)

CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
por: Scheffler, Armin, et al.
Publicado: (2021)

The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow
por: Dux, Mária, et al.
Publicado: (2022)

Post-Dural Puncture Headache
por: Wrobel, Marc, et al.
Publicado: (2012)

A rare cause of occipital headache
por: Saini, Lokesh, et al.
Publicado: (2015)

A computerized expert system for diagnosing primary headache based on International Classification of Headache Disorder (ICHD-II)
por: Eslami, Vahid, et al.
Publicado: (2013)

Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Successful treatment of nummular headache with Neurotropin(®)
por: Yamazaki, Yuu, et al.
Publicado: (2011)

Is headache related with Vitamin D insufficiency?
por: Yang, Yi, et al.
Publicado: (2010)

Epigenetics and pharmaco-epigenetics in the primary headaches
por: Montagna, Pasquale
Publicado: (2008)

Pregabalin for refractory postdural puncture headache
por: Yadav, Anamika, et al.
Publicado: (2015)

A case of tension-type headache in fibromyalgia
por: Stifano, Giuseppina, et al.
Publicado: (2010)

The Polish Headache Society and the Headache Section of the Polish Neurological Society Consensus Statement: update on new pharmacological therapies for migraine in clinical practice and public medication reimbursement program for chronic migraine
por: Domitrz, Izabela, et al.
Publicado: (2022)

Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one
por: Fresán-Restituto, Daniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_evpqslp83j2605gr9gpoeevbkj